STEM与日常科技·英语精读30篇（4）
23 / 30
正在确认阅读权限…
CRISPR Beyond Editing: Diagnostic Sensitivity and Off-Target Reporting in Clinical Labs
超越基因编辑的CRISPR：临床实验室中的检测灵敏度与脱靶报告
-
Clinical CRISPR assays now prioritize analytical sensitivity over editing efficiency—detecting single-copy viral RNA at attomolar concentrations.临床CRISPR检测目前更注重分析灵敏度，而非编辑效率——可检出阿摩尔浓度级别的单拷贝病毒RNA。
-
FDA EUA submissions for CRISPR-based SARS-CoV-2 tests require validated off-target binding reports using cell-free genomic DNA libraries.基于CRISPR的SARS-CoV-2检测试剂向FDA申请紧急使用授权（EUA）时，须提交经验证的脱靶结合报告，使用无细胞基因组DNA文库完成。
-
Lab directors compare CRISPR-Cas12a lateral flow assays not by speed but by limit-of-detection consistency across humidity gradients.实验室主管评估CRISPR-Cas12a侧流层析检测，关注的不是速度，而是不同湿度梯度下的检出限一致性。
-
Pathology labs audit CRISPR guide RNA batches for batch-to-batch cleavage fidelity—measured via digital droplet PCR quantification of unintended cuts.病理实验室对CRISPR向导RNA（gRNA）批次进行审计，重点核查批间切割保真度——通过数字微滴PCR定量非预期切割来测定。
-
Reagent stability claims now include temperature-dependent collateral cleavage decay rates, not just shelf-life expiration dates.试剂稳定性声明如今需包含温度依赖性的附带切割衰减速率，而不仅标注货架期截止日期。
-
CLIA-certified labs report CRISPR assay failures more often due to crRNA secondary structure misfolding than Cas protein denaturation.CLIA认证实验室报告CRISPR检测失败，更多源于crRNA二级结构错误折叠，而非Cas蛋白变性。
-
Hospital infection control teams use CRISPR detection turnaround time—not sequencing depth—to triage ICU cohorting decisions.医院感染控制团队依据CRISPR检测的周转时间（而非测序深度）决定ICU患者分组策略。
-
Vendor technical support now troubleshoots false positives by analyzing gRNA off-target scores from GUIDE-seq databases, not instrument calibration logs.厂商技术支持排查假阳性问题时，优先分析GUIDE-seq数据库中的gRNA脱靶评分，而非仪器校准日志。
-
Billing codes for CRISPR diagnostics now require documentation of specificity validation against 500+ human SNP variants per target region.CRISPR诊断项目的医保编码现要求提供特异性验证文件，须针对每个靶区至少500种人类SNP变异进行验证。
-
Point-of-care CRISPR devices embed real-time fluorescence quenching correction algorithms originally developed for single-molecule FRET studies.即时检测（POC）CRISPR设备嵌入了实时荧光淬灭校正算法，该算法最初源自单分子FRET研究。
-
What clinicians trust isn’t the ‘cutting’ metaphor—it’s the certified false-negative rate across sample matrix variations like heparinized blood or sputum mucus.临床医生信赖的并非‘剪切’这一比喻，而是经认证的假阴性率——涵盖肝素抗凝血、痰液黏液等不同样本基质的变异。
-
Your lab’s accreditation hinges on proving CRISPR’s diagnostic reliability—not its gene-editing potential.贵实验室的资质认证取决于CRISPR诊断可靠性的实证，而非其基因编辑潜力。